medicare semaglutide Millions of beneficiaries to get affordable weight-loss drugs Medicare launches weight loss drug

When varying the grace period between 60 days and 365 days, treatment discontinuation rates at 3 years ranged from 23.3% to 43.6% among GLP-1 receptor agonist users and from 28.8% to 50.6% among SGLT2 inhibitor users

Ahrn, B., Masmiquel, L., Kumar, H., Sargin, M., Karsbl, J

It is approved by the Food and Drug Administration (FDA) for weight loss and long-term weight management in adults and adolescents 12 years and older with obesity, as well as adults who are overweight and have at least one weight-related health condition, such as high cholesterol or Type 2 diabetes

This rapid heart rate (tachycardia) is the body's scramble to get oxygen to your vital tissues, and you feel it as palpitations